K - Mylan's COVID-19 Medicine And Other News: The Good Bad And Ugly Of Biopharma
Mylan Resurrects Old Malaria Medication to Fight COVID-19
Mylan (MYL) reported that it has decided to restart the production of hydroxychloroquine sulfate tablets. The restart is to allow the use of these tablets as potential treatment of COVID-19. It is expected that the tablets will be available in the market by mid April. The tablet is currently approved to be used for treating malaria. Hydroxychloroquine is also approved to be used for treating some autoimmune diseases due to its anti-inflammatory properties and lower toxicity.
Mylan is currently looking to manufacture tablets in its